
FDA Approves Amondys 45
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in
April 30 will mark the end of the first 100 days of President Joe Biden’s
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-MACROGOL PLUS
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BETALOC®INJECTION Metoprolol
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PANAMAX Paracetamol
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. IKOTAB nicorandil
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. HYDROCORTISONE MYLAN
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SOLIFENACIN MYLAN
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RABIPUR (Rab-ee-per)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LONQUEX® CMI